Found 18 matching trials
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies PHASE1 This is a Phase 1b/2 protocol to evaluate pharmacokinetics, safety, efficac...
Show More Location
Beijing Cancer hospital
Learn More & Join Trial
Ketohexokinase Inhibition in Hereditary Fructose Intolerance PHASE2 Hereditary fructose intolerance (HFI) is a rare inborn error of metabolism....
Show More Location
Maastricht University Medical centre
Learn More & Join Trial
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. PHASE1 Open-label, multi-center, non-randomized, multiple dose, safety, tolerabili...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. PHASE1 The purpose of this study is to learn about the safety and effects of the s...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer PHASE1 The purpose of this study is to learn how a new medicine called PF-08052667...
Show More Location
The Kirklin Clinic of UAB Hospital
Learn More & Join Trial
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor PHASE2 This study investigates whether a single subcutaneous administration of ant...
Show More Location
Eberhard Karls Universitaet Tuebingen (EKUT)
Learn More & Join Trial
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors PHASE1 The purpose of this study is to assess the safety and effects of PF-0726502...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma PHASE2 The goal of this research study is to evaluate how well and safely the stud...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies PHASE1 The purpose of this study is to learn about the safety and the effects of P...
Show More Location
Presbyterian/ St. Lukes Medical Center
Learn More & Join Trial
Study of PF-07265807 in Participants With Metastatic Solid Tumors. PHASE1 A First-in-Human Pharmacokinetic, Safety, and Tolerability Study of PF-0726...
Show More Learn More & Join Trial